drugset / Trial / NCT05997563

Adjunctive Vaginal Progesterone in Management of Preterm Labor

NCT05997563

Phase 4 Unknown 48 enrolled Chulalongkorn University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates the addition of vaginal micronized progesterone effervescent to standard treatment in the treatment of preterm labor. Half of participants will receive vaginal micronized progesterone effervescent and standard treatment, while the other half will receive only standard treatment.

Timeline

Start
2023-08-16
Primary completion
2025-08-31
Completion
2025-10-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified Intravenous

Indications

No indication recorded.